Today: 13 June 2026
Browse Category

NYSE:CANF 18 November 2025

Can-Fite BioPharma (CANF) Soars on 9-Year Liver Cancer Survival Breakthrough with Namodenoson – November 18, 2025

Can-Fite BioPharma (CANF) Soars on 9-Year Liver Cancer Survival Breakthrough with Namodenoson – November 18, 2025

Can-Fite BioPharma shares surged over 30% Tuesday after reporting a patient with advanced hepatocellular carcinoma remained cancer-free for nine years on its drug Namodenoson. The company also began enrolling patients in a pivotal Phase III trial for the treatment in Israel, Europe, and the U.S. Namodenoson holds Orphan Drug and Fast Track designations.
18 November 2025
···

Stock Market Today

  • Kalshi’s Lopes Lara on Building a Billion-Dollar Prediction Market from Celebrity Buzz
    June 13, 2026, 1:02 PM EDT. Kalshi co-founder Lopes Lara revealed how celebrity gossip, including the buzz around Kylie Jenner, inspired her dive into prediction markets-platforms where users bet on event outcomes. She discussed navigating legal challenges facing Kalshi amid regulatory scrutiny. Lopes Lara also shared insights from advice given by Jay-Z, emphasizing resilience and innovation. Her journey highlights the rising influence of alternative financial markets tied to real-world events, reflecting growing investor interest in novelty trading platforms beyond traditional stocks and commodities.

Latest articles

PayPal Stock Near $41 as July Earnings Loom After Market Rally

PayPal Stock Near $41 as July Earnings Loom After Market Rally

13 June 2026
PayPal closed at $41.53, up 0.7%, as investors weigh a low P/E of 7.8 and $1.5 billion in Q1 buybacks against falling GAAP margins, weak near-term profit guidance, and a recent slip in active accounts; the next major catalyst is PayPal’s Q2 earnings call on July 28.
Berkshire Hathaway Shares Up With Taylor Morrison Deal Vote Ahead

Berkshire Hathaway Shares Up With Taylor Morrison Deal Vote Ahead

13 June 2026
Berkshire Hathaway Class B shares closed up 0.71% at $489.25 after a key proxy filing advanced its $8.5 billion all-cash Taylor Morrison acquisition, spotlighting CEO Greg Abel’s capital allocation strategy as investors weigh modest valuation appeal against housing-cycle risks and await the shareholder vote as the next major catalyst.
Go toTop